San Francisco, CA, United States of America

Morgan Lawrenz

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Nurix Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Morgan Lawrenz. Retrieved from https://idiyas.com/inventor/morgan-lawrenz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Morgan Lawrenz - Innovator in Pharmaceutical Compounds

Introduction

Morgan Lawrenz is an inventor based in New York, NY (US). He is focused on developing innovative solutions in the field of pharmaceuticals. His work primarily revolves around compounds that have potential applications in treating serious health conditions.

Latest Patent Applications

Morgan Lawrenz has submitted a patent application titled "TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS." This application relates to compounds of Formula (I), as defined within the document, and includes pharmaceutically acceptable salts thereof. The application also describes pharmaceutical compositions comprising these compounds and methods for using them to treat diseases such as cancer, autoimmune disorders, and inflammatory disorders.

Conclusion

Morgan Lawrenz is an emerging inventor whose work in pharmaceutical compounds shows promise for addressing significant health challenges. His innovative approach may lead to advancements in the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…